Multiscale models of breast cancer progression

Annals of Biomedical Engineering

Volumn 40, Issue 11, 2012, Pages 2488-2500

  Chakrabarti, Anirikh ^a   Verbridge, Scott ^a   Stroock, Abraham D ^a   Fischbach, Claudia ^a   Varner, Jeffrey D ^a  

^a Cornell University   (United States)

Author keywords

Angiogenesis; Breast cancer; Hypoxia; Multiscale modeling

Indexed keywords

AGENT-BASED MODEL; ANGIOGENESIS; BIO-MOLECULAR; BREAST CANCER; CANCER CELLS; EX-VIVO; EXPERIMENTAL MODELS; HYPOXIA; INTRACELLULAR SIGNALS; LENGTH SCALE; MICROENVIRONMENTS; MOLECULAR EVENTS; MOLECULAR SIGNALING; MULTI-SCALE MODELING; MULTI-SCALE SIMULATION; MULTIPLE CELL TYPES; MULTISCALE MODELS; MULTISCALES; PLATFORM TECHNOLOGY; SCIENTIFIC DISCOVERY; STATE OF THE ART; SUB-CELLULAR; SUBCELLULAR SCALE; THERAPEUTIC TARGETS; TIME-SCALES; TOPDOWN; TUMOR SITE;

COMPUTER SIMULATION; ENZYME ACTIVITY; MATHEMATICAL MODELS; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

DISEASES;

BIOLOGICAL MODEL; BREAST TUMOR; DISEASE COURSE; FEMALE; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; VASCULARIZATION;

BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84868375378     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-012-0655-8     Document Type: Article

References (153)

1. Abbott, R. G., S. Forrest, and K.J. Pienta. Simulating the hallmarks of cancer. Artif. Life 12:617-634, 2006.
2. Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J. et al.: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6:17-32, 2004.
3. Ananiadou, S., D. B. Kell, and J. I. Tsujii. Text mining and its potential applications in systems biology. Trends Biotechnol. 24:571-579, 2006.
4. Andasari, V., R. T. Roper, M. H. Swat, and M. A. J. Chaplain. Integrating intracellular dynamics using CompuCell3D and Bionetsolver: applications to multiscale modelling of cancer cell growth and invasion. PLoS One 7:e33726, 2012.
5. Anderson, A. R. A., K. A. Rejniak, P. Gerlee, and V. Quaranta. Microenvironment driven invasion: a multiscale multimodel investigation. J. Math. Biol. 58:579-624, 2009.
6. Aoki-Kinoshita, K. F., and M. Kanehisa. Gene annotation and pathway mapping in KEGG. Methods Mol. Biol. 396:71-91, 2007.
7. Asthagiri, A. R., and D. A. Lauffenburger. A computational study of feedback effects on signal dynamics in a mitogen-activated protein kinase (MAPK) pathway model. Biotechnol. Prog. 17:227-239, 2001.
8. Athale, C. A., and T. S. Deisboeck. The effects of EGFreceptor density on multiscale tumor growth patterns. J. Theor. Biol. 238:771-779, 2006.
9. Bailey, A. M., B. C. Thorne, and S. M. Peirce. Multi-cell agent-based simulation of the microvasculature to study the dynamics of circulating inflammatory cell trafficking. Ann. Biomed. Eng. 35:916-936, 2007.
10. Balmain, A., J. Gray, and B. Ponder. The genetics and genomics of cancer. Nat. Genet. 33(Suppl):238-244, 2003.
11. Bandara, S., J. P. Schlöder, R. Eils, H. G. Bock, and T. Meyer. Optimal experimental design for parameter estimation of a cell signaling model. PLoS Comput. Biol. 5:e1000558, 2009.
12. Barnes, P. J., and M. Karin. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071, 1997.
13. Battogtokh, D., D. K. Asch, M. E. Case, J. Arnold, and H. B. Schuttler. An ensemble method for identifying regulatory circuits with special reference to the QA gene cluster of Neurospora crassa. Proc. Natl. Acad. Sci. U S A 99:16904-16909, 2002.
14. Benoy, I. H., R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin. Cancer Res. 10:7157-7162, 2004.
15. Bergers, G., and D. Hanahan. Modes of resistance to antiangiogenic therapy. Nat. Rev. Cancer 8:592-603, 2008.
16. Bertos, N. R., and M. Park. Breast cancer - one term, many entities. J. Clin. Invest. 121:3789-3796, 2011.
17. Bonabeau, E. Agent-based modeling: methods and techniques for simulating human systems. Proc. Natl. Acad. Sci. U S A 99(Suppl 3):7280-7287, 2002.
18. Brahimi-Horn, M. C., J. Chiche, and J. Pouysségur. Hypoxia and cancer. J. Mol. Med. (Berl.) 85:1301-1307, 2007.
19. Brown, K. S., and J. P. Sethna. Statistical mechanical approaches to models with many poorly known parameters. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 68:021904, 2003.
20. Brown, K. S., C. C. Hill, G. A. Calero, C. R. Myers, K. H. Lee et al. The statistical mechanics of complex signaling networks: nerve growth factor signaling. Phys. Biol. 1:184-195, 2004.
21. Cabodi, M., N. W. Choi, J. P. Gleghorn, C. S. D. Lee, L. J. Bonassar, et al. A microfluidic biomaterial. J. Am. Chem. Soc. 127:13788-13789, 2005.
22. Chao, D. L., M. E. Halloran, V. J. Obenchain, Longini, I. M., Jr. Flute, a publicly available stochastic influenza epidemic simulation model. PLoS Comput. Biol. 6: e1000656, 2010.
23. Chavali, A. K., E. P. Gianchandani, K. S. Tung, M. B. Lawrence, S. M. Peirce, et al. Characterizing emergent properties of immunological systems with multi-cellular rule-based computational modeling. Trends Immunol. 29:589-599, 2008.
24. Chen, W. W., B. Schoeberl, P. J. Jasper, M. Niepel, U. B. Nielsen, et al. Input-output behavior of ERBB signaling pathways as revealed by a mass action model trained against dynamic data. Mol. Syst. Biol. 5:239, 2009.
25. Chin, K., C. O. de Solorzano, D. Knowles, A. Jones, W. Chou, et al. In situ analyses of genome instability in breast cancer. Nat. Genet. 36:984-988, 2004.
26. Choi, N. W., M. Cabodi, B. Held, J. P. Gleghorn, L. J. Bonassar, et al. Microfluidic scaffolds for tissue engineering. Nat. Mater. 6:908-915, 2007.
27. Choueiri, T. K., E. L. Mayer, Y. Je, J. E. Rosenberg, P. L. Nguyen, et al. Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J. Clin. Oncol. 29:632-638, 2011.
28. Chrobak, K. M., D. R. Potter, J. Tien. Formation of perfused, functional microvascular tubes in vitro. Microvasc. Res. 71:185-196, 2006.
29. Correia, A. L., and M. J. Bissell. The tumor microenvironment is a dominant force in multidrug resistance. Drug. Resist. Updat. 15:39-49, 2012.
30. Das, A., D. Lauffenburger, H. Asada, and R. D. Kamm. A hybrid continuum-discrete modelling approach to predict and control angiogenesis: analysis of combinatorial growth factor and matrix effects on vessel-sprouting morphology. Philos. Trans. A Math. Phys. Eng. Sci. 368:2937-2960, 2010.
31. Deisboeck, T. S., and G. S. Stamatakos (eds.). Multiscale Cancer Modeling. Boca Raton, FL: CRC Press, 2010.
32. Deisboeck, T. S., Z. Wang, P. Macklin, V. Cristini. Multiscale cancer modeling. Annu. Rev. Biomed. Eng. 13:127-155, 2011.
33. Dittrich, P. S., and A. Manz. Lab-on-a-chip: microfluidics in drug discovery. Nat. Rev. Drug Discov. 5:210-218, 2006.
34. Dvorak, H. F. Tumors: wounds that do not heal. similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1650-1659, 1986.
35. Ebos, J. M. L., C. R. Lee, J. G. Christensen, A. J. Mutsaers, and R. S. Kerbel. Multiple circulating proangiogenic factors induced by sunitinib malate are tumorindependent and correlate with antitumor efficacy. Proc. Natl Acad. Sci. U S A 104:17069-17074, 2007.
36. Ebos, J. M. L., C. R. Lee, W. Cruz-Munoz, G. A. Bjarnason, J. G. Christensen, et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15:232-239, 2009.
37. Engler, A. J., P. O. Humbert, B. Wehrle-Haller, and V. M. Weaver. Multiscale modeling of form and function. Science 324:208-212, 2009.
38. Faro, A., D. Giordano, and C. Spampinato. Combining literature text mining with microarray data: advances for system biology modeling. Brief Bioinform. 13:61-82, 2012.
39. Ferrara, N., H. P. Gerber, and J. LeCouter. The biology of VEGF and its receptors. Nat. Med. 9:669-676, 2003.
40. Ferrara, N., K. J. Hillan, H. P. Gerber, and W. Novotny. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 3:391-400, 2004.
41. Fields, S., and R. Sternglanz. The two-hybrid system: an assay for protein-protein interactions. Trends Genet. 10:282-292, 1994.
42. Fischbach, C., R. Chen, T. Matsumoto, T. Schmelzle, J. S. Brugge, et al. Engineering tumors with 3D scaffolds. Nat. Methods 4:855-860, 2007.
43. Fischbach, C., H. J. Kong, S. X. Hsiong, M. B. Evangelista, W. Yuen, et al. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc. Natl Acad. Sci. U S A 106:399-404, 2009.
44. Flohé, L., R. Brigelius-Flohé, C. Saliou, M. G. Traber, and L. Packer. Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 22:1115-1126, 1997.
45. Frieboes, H. B., M. E. Edgerton, J. P. Fruehauf, F. R. A. J. Rose, L. K. Worrall, et al. Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res. 69:4484-4492, 2009.
46. Gadkar, K. G., J. Varner, and F. J. Doyle. Model identification of signal transduction networks from data using a state regulator problem. Syst. Biol. (Stevenage) 2:17-30, 2005.
47. Gennemark, P., and D. Wedelin. Benchmarks for identification of ordinary differential equations from time series data. Bioinformatics 25:780-786, 2009.
48. Gerlee, P., and A. R. A. Anderson. Modelling evolutionary cell behaviour using neural networks: application to tumour growth. Biosystems 95:166-174, 2009.
49. Gerlee, P., and A. R. A. Anderson. Evolution of cell motility in an individual-based model of tumour growth. J. Theor. Biol. 259:67-83, 2009.
50. Grant, M. R., K. E. Mostov, T. D. Tlsty, and C. A. Hunt. Simulating properties of in vitro epithelial cell morphogenesis. PLoS Comput. Biol. 2:e129, 2006.
51. Grimm, V., E. Revilla, U. Berger, F. Jeltsch, W. M. Mooij, et al. Pattern-oriented modeling of agent-based complex systems: lessons from ecology. Science 310:987-991, 2005.
52. Grunewald, M., I. Avraham, Y. Dor, E. Bachar-Lustig, A. Itin, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 24:175-189, 2006.
53. Gupta, A., J. Varner, and C. Maranas. Large-scale inference of the transcriptional regulation of Bacillus subtilis. Comput. Chem. Eng. 29:565-576, 2005.
54. Gutenkunst, R. N., J. J. Waterfall, F. P. Casey, K. S. Brown, C. R. Myers, et al. Universally sloppy parameter sensitivities in systems biology models. PLoS Comput. Biol. 3:1871-1878, 2007.
55. Hanahan, D., and R. A. Weinberg. The hallmarks of cancer. Cell 100:57-70, 2000.
56. Harris, A. L. Hypoxia - a key regulatory factor in tumour growth. Nat Rev. Cancer 2:38-47, 2002.
57. Hattne, J., D. Fange, and J. Elf. Stochastic reaction-diffusion simulation with MesoRD. Bioinformatics 21:2923-2924, 2005.
58. Higgins, M. J., and J. Baselga. Targeted therapies for breast cancer. J. Clin. Invest. 121:3797-3803, 2011.
59. Hinow, P., P. Gerlee, L. J. McCawley, V. Quaranta, M. Ciobanu, et al. A spatial model of tumor-host interaction: application of chemotherapy. Math. Biosci. Eng. 6:521-546, 2009.
60. Hornbeck, P. V., J. M. Kornhauser, S. Tkachev, B. Zhang, E. Skrzypek, et al. Phosphositeplus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40:D261-D70, 2012.
61. Hornberg, J. J., B. Binder, F. J. Bruggeman, B. Schoeberl, R. Heinrich, et al. Control of MAPK signalling: from complexity to what really matters. Oncogene 24:5533-5542, 2005.
62. Huang, Y., B. Agrawal, D. Sun, J. S. Kuo, and J. C. Williams. Microfluidics-based devices: new tools for studying cancer and cancer stem cell migration. Biomicrofluidics 5:13412, 2011.
63. Huh, D., Y. S. Torisawa, G. A. Hamilton, H. J. Kim, and D. E. Ingber. Microengineered physiological biomimicry: organs-on-chips. Lab Chip 12:2156-2164, 2012.
64. Iliopoulos, D., H. A. Hirsch, and K. Struhl. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139:693-706, 2009.
65. Jain, R. K., and L. T. Baxter. Mechanisms of heterogeneous distribution of monoclonal antibodies and otherv macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 48:7022-7032, 1988.
66. Jemal, A., F. Bray, M. M. Center, J. Ferlay, E. Ward, et al. Global cancer statistics. CA Cancer J. Clin. 61:69-90, 2011.
67. Jensen, L. J., M. Kuhn, M. Stark, S. Chaffron, C. Creevey, et al. String 8 - a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 37: D412-D416, 2009.
68. Jeong, G. S., S. Han, Y. Shin, G. H. Kwon, R. D. Kamm, et al. Sprouting angiogenesis under a chemical gradient regulated by interactions with an endothelial monolayer in a microfluidic platform. Anal. Chem. 83:8454-8459, 2011.
69. Jones, S., X. Zhang, D. W. Parsons, J. C. H. Lin, R. J. Leary, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806, 2008.
70. Kaplan, R. N., R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827, 2005.
71. Karlebach, G., and R. Shamir. Modelling and analysis of gene regulatory networks. Nat. Rev. Mol. Cell Biol. 9:770-780, 2008.
72. Kerbel, R. S.: Tumor angiogenesis. N. Engl. J. Med. 358:2039-2049, 2008.
73. Korkaya, H., S. Liu, and M. S. Wicha. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 121:3804-3809, 2011.
74. Kuepfer, L., M. Peter, U. Sauer, and J. Stelling. Ensemble modeling for analysis of cell signaling dynamics. Nat. Biotechnol. 25:1001-1006, 2007.
75. LaBarge, M. A., C. M. Nelson, R. Villadsen, A. Fridriksdottir, J. R. Ruth, et al. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integr. Biol. (Camb.) 1:70-79, 2009.
76. Lazzara, M. J., and D. A. Lauffenburger. Quantitative modeling perspectives on the ERBB system of cell regulatory processes. Exp. Cell Res. 315:717-725, 2009.
77. Lequieu, J., A. Chakrabarti, S. Nayak, and J. D. Varner. Computational modeling and analysis of insulin induced eukaryotic translation initiation. PLoS Comput. Biol. 7:e1002263, 2011.
78. Li, C., M. Donizelli, N. Rodriguez, H. Dharuri, L. Endler, et al. Biomodels database: an enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst. Biol. 4:92, 2010.
79. Liao, D., C. Corle, T. N. Seagroves, and R. S. Johnson. Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 67:563-72, 2007.
80. Linding, R., L. J. Jensen, G. J. Ostheimer, M. A. T. M. van Vugt, C. Jorgensen, et al. Systematic discovery of in vivo phosphorylation networks. Cell 129, 1415-1426, 2007.
81. Liu, G., A. A. Qutub, P. Vempati, F. Mac Gabhann, and A. S. Popel. Module-based multiscale simulation of angiogenesis in skeletal muscle. Theor. Biol. Med. Model. 8:6, 2011.
82. Liu, S., C. Ginestier, S. J. Ou, S. G. Clouthier, S. H. Patel, et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 71:614-624, 2011.
83. Locasale, J. W., and A. Wolf-Yadlin. Maximum entropy reconstructions of dynamic signaling networks from quantitative proteomics data. PLoS One 4: e6522, 2009.
84. Loges, S., T. Schmidt, and P. Carmeliet. "Antimyeloangiogenic" therapy for cancer by inhibiting PLGF. Clin. Cancer Res. 15:3648-3653, 2009.
85. Lu, L., and S. Pope. An improved algorithm for in situ adaptive tabulation. J. Comput. Phys. 228:361-386, 2009.
86. Lu, P., V. M. Weaver, and Z. Werb. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196:395-406, 2012.
87. Luan, D., F. Szlam, K. A. Tanaka, P. S. Barie, and J. D. Varner. Ensembles of uncertain mathematical models can identify network response to therapeutic interventions. Mol. Biosyst. 6:2272-2286, 2010.
88. Lutolf, M. P., and J. A. Hubbell. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23:47-55, 2005.
89. Ma, X. J., S. Dahiya, E. Richardson, M. Erlander, and D. C. Sgroi. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 11:R7, 2009.
90. Macklin, P., J. Kim, G. Tomaiuolo, M. Edgerton, and V. Cristini. Agent-based modeling of ductal carcinoma in situ: application to patient-specific breast cancer modeling. In: Computational Biology Issues and Applications in Oncology, edited by T. D. Pharm. New York: Springer, 2010, pp. 77-111.
91. Macklin, P., S. McDougall, A. R. A. Anderson, M. A. J. Chaplain, V. Cristini, et al. Multiscale modelling and nonlinear simulation of vascular tumour growth. J. Math. Biol. 58:765-798, 2009.
92. MacQuarrie, K. L., A. P. Fong, R. H. Morse, S. J. Tapscott. Genome-wide transcription factor binding: beyond direct target regulation. Trends Genet. 27:141-148, 2011.
93. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. Cancer-related inflammation. Nature 454:436-44, 2008.
94. Massey, S. C., M. C. Assanah, K. A. Lopez, P. Canoll, and K. R. Swanson. Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling. J. R. Soc. Interface 9(73):1757-1766, 2012.
95. Mayawala, K., C. A. Gelmi, and J. S. Edwards. MAPK cascade possesses decoupled controllability of signal amplification and duration. Biophys. J. 87:L01-L02, 2004.
96. Meng, X., J. Zhong, S. Liu, M. Murray, and A. M. Gonzalez-Angulo. A new hypothesis for the cancer mechanism. Cancer Metastasis Rev. 31(1-2):247-268, 2011.
97. Metropolis, N., A. Rosenbluth, M. Rosenbluth, A. Teller, and E. Teller. Equation of state calculations by fast computing machines. J. Chem. Phys. 21:1087-1093, 1953.
98. Miles, D. W., A. Chan, L.Y. Dirix, J. Cortés, X. Pivot, et al. Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. J. Clin. Oncol. 28:3239-3247, 2010.
99. Milo, R., S. Shen-Orr, S. Itzkovitz, N. Kashtan, D. Chklovskii, et al. Network motifs: simple building blocks of complex networks. Science 298:824-827, 2002.
100. Mizukami, Y., Y. Kohgo, and D. C. Chung. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clin. Cancer Res. 13:5670-5674, 2007.
101. Mori, H., N. Gjorevski, J. L. Inman, M. J. Bissell, C. M. Nelson. Self-organization of engineered epithelial tubules by differential cellular motility. Proc. Natl Acad. Sci. U S A 106:14890-14895, 2009.
102. Moussaïd, M., E. G. Guillot, M. Moreau, J. Fehrenbach, O. Chabiron, et al. Traffic instabilities in self-organized pedestrian crowds. PLoS Comput. Biol. 8:e1002442, 2012.
103. Nakatsu, M. N., J. Davis, and C. C. W. Hughes. Optimized fibrin gel bead assay for the study of angiogenesis. J. Vis. Exp. 3:186, 2007.
104. Navin, N., J. Kendall, J. Troge, P. Andrews, L. Rodgers, et al. Tumour evolution inferred by single-cell sequencing. Nature 472:90-94, 2011.
105. Nelson, C. M., J. L. Inman, and M. J. Bissell. Threedimensional lithographically defined organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic progression. Nat Protoc. 3:674-678, 2008.
106. Nguyen, L. V., R. Vanner, P. Dirks, and C. J. Eaves. Cancer stem cells: an evolving concept. Nat. Rev. Cancer 12:133-143, 2012.
107. Owen, M. R., T. Alarcón, P. K. Maini, and H. M. Byrne. Angiogenesis and vascular remodelling in normal and cancerous tissues. J. Math. Biol. 58:689-721, 2009.
108. Pààez-Ribes, M., E. Allen, J. Hudock, T. Takeda, H. Okuyama, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220-231, 2009.
109. Palmer, T., G. Shutts, R. Hagedorn, F. Doblas-Reyes, Y. Jung, et al. Representing model uncertainty in weather and climate prediction. Annu. Rev Earth Planetary Sci. 33:163-193, 2005.
110. Patocs, A., L. Zhang, Y. Xu, F. Weber, T. Caldes, et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N. Engl. J. Med. 357:2543-2551, 2007.
111. Peirce, S. M., F. M. Gabhann, and V. L. Bautch. Integration of experimental and computational approaches to sprouting angiogenesis. Curr. Opin. Hematol. 19(3):184-191, 2012.
112. Peirce, S. M., E. J. Van Gieson, and T. C. Skalak. Multicellular simulation predicts microvascular patterning and in silico tissue assembly. FASEB J. 18:731-733, 2004.
113. Perfahl, H., H. M. Byrne, T. Chen, V. Estrella, T. Alarcón, et al. Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions. PLoS One 6:e14790, 2011.
114. Perou, C. M., T. Sorlie, M. B. Eisen, M. van de Rijn, S. S. Jeffrey, et al. Molecular portraits of human breast tumours. Nature 406:747-752, 2000.
115. Polyak, K. Breast cancer: origins and evolution. J. Clin. Invest. 117:3155-3163, 2007.
116. Polyak, K., I. Haviv, I. G. Campbell. Co-evolution of tumor cells and their microenvironment. Trends Genet. 25:30-38, 2009.
117. Pugh, C. W., and P. J. Ratcliffe. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:677-684, 2003.
118. Quo, C. F., C. Kaddi, J. H. Phan, A. Zollanvari, M. Xu, et al. Reverse engineering biomolecular systems using -omic data: challenges, progress and opportunities. Brief Bioinform. 13:430-445, 2012.
119. Qutub, A. A., F. Mac Gabhann, E. D. Karagiannis, P. Vempati, A. S. Popel. Multiscale models of angiogenesis. IEEE Eng. Med. Biol. Mag. 28:14-31, 2009.
120. Rao, B. M., D. A. Lauffenburger, and K. D. Wittrup. Integrating cell-level kinetic modeling into the design of engineered protein therapeutics. Nat. Biotechnol. 23:191-194, 2005.
121. Rejniak, K. A., and A. R. A. Anderson. State of the art in computational modelling of cancer. Math. Med. Biol. 29:1-2, 2012.
122. Rejniak, K. A., S. E. Wang, N. S. Bryce, H. Chang, B. Parvin, et al. Linking changes in epithelial morphogenesis to cancer mutations using computational modeling. PLoS Comput. Biol. 6:e1000900, 2010.
123. Saez-Rodriguez, J., L. G. Alexopoulos, J. Epperlein, R. Samaga, and D. A. Lauffenburger, et al. Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol. Syst. Biol. 5:331, 2009.
124. Salgado, R., S. Junius, I. Benoy, P. Van Dam, P. Vermeulen, et al. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int. J. Cancer 103:642-646, 2003.
125. Sansone, P., G. Storci, S. Tavolari, T. Guarnieri, C. Giovannini, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117:3988-4002, 2007.
126. Schafer, Z. T., and J. S. Brugge. IL-6 involvement in epithelial cancers. J. Clin. Invest. 117:3660-3663, 2007.
127. Shieh, A. C. Biomechanical forces shape the tumor microenvironment. Ann. Biomed. Eng. 39:1379-1389, 2011.
128. Shin, Y., J. S. Jeon, S. Han, G. S. Jung, S. Shin, et al. In vitro 3D collective sprouting angiogenesis under orchestrated ANG-1 and VEGF gradients. Lab Chip 11:2175-2181, 2011.
129. Sklar, E.: Netlogo, a multi-agent simulation environment. Artif. Life 13:303-311, 2007.
130. Song, S. O., A. Chakrabarti, and J. D. Varner. Ensembles of signal transduction models using pareto optimal ensemble techniques (POETs). Biotechnol. J. 5:768-780, 2010.
131. Song, S. O., and J. Varner. Modeling and analysis of the molecular basis of pain in sensory neurons. PLoS One 4:e6758, 2009.
132. Song, S. O. K., J. Hogg, Z. Y. Peng, R. Parker, J. A. Kellum, et al. Ensemble models of neutrophil trafficking in severe sepsis. PLoS Comput. Biol. 8:e1002422, 2012.
133. Sorlie, T., C. M. Perou, R. Tibshirani, T. Aas, S. Geisler, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. U S A 98:10869-10874, 2001.
134. Spencer, S. L., R. A. Gerety, K. J. Pienta, and S. Forrest. Modeling somatic evolution in tumorigenesis. PLoS Comput. Biol. 2:e108, 2006.
135. Swanson, K. R., E. C. Alvord, Jr., and J. D. Murray. Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery. Acta Biotheor. 50:223-237, 2002.
136. Swanson, K. R., C. Bridge, J. D. Murray, and E. C. Alvord, Jr. Virtual and real brain tumors: using mathe-matical modeling to quantify glioma growth and invasion. J. Neurol. Sci. 216:1-10, 2003.
137. Swanson, K. R., L. D. True, and J. D. Murray. On the use of quantitative modeling to help understand prostatespecific antigen dynamics and other medical problems. Am. J. Clin. Pathol. 119:14-17, 2003.
138. Tasseff, R., S. Nayak, S. Salim, P. Kaushik, N. Rizvi, et al. Analysis of the molecular networks in androgen dependent and independent prostate cancer revealed fragile and robust subsystems. PLoS One 5:e8864, 2010.
139. Tasseff, R., S. Nayak, S. O. Song, A. Yen, and D. Varner. Modeling and analysis of retinoic acid induced differentiation of uncommitted precursor cells. Integr. Biol. (Camb.) 3:578-591, 2011.
140. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442-454, 2002.
141. Thorne, B. C., A. M. Bailey, and S. M. Peirce. Combining experiments with multi-cell agent-based modeling to study biological tissue patterning. Brief Bioinform. 8:245-257, 2007.
142. Varner, J. D. Systems biology and the mathematical modelling of antibody-directed enzyme prodrug therapy (ADEPT). Syst. Biol. (Stevenage) 152:291-302, 2005.
143. Wang, Z., V. Bordas, and T. S. Deisboeck. Discovering molecular targets in cancer with multiscale modeling. Drug. Dev. Res. 72:45-52, 2011.
144. Wang, Z., V. Bordas, J. Sagotsky, and T. S. Deisboeck. Identifying therapeutic targets in a combined EGFRTGFBR signalling cascade using a multiscale agent-based cancer model. Math. Med. Biol. 29:95-108, 2012.
145. Wang, J., Y. Zhang, C. Marian, and H. W. Ressom. Identification of aberrant pathways and network activities from high-throughput data. Brief Bioinform. 13:406-419, 2012.
146. Waugh, D. J. J., and C. Wilson. The interleukin-8 pathway in cancer. Clin. Cancer Res. 14:6735-6741, 2008.
147. Yao, J., S. Weremowicz, B. Feng, R. C. Gentleman, J. R. Marks, et al. Combined CDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res. 66:4065-4078, 2006.
148. Yarden, Y., and M. X. Sliwkowski. Untangling the erbb signalling network. Nat. Rev. Mol. Cell Biol. 2:127-137, 2001.
149. Yeung, M. K. S., J. Tegnér, and J. J. Collins. Reverse engineering gene networks using singular value decomposition and robust regression. Proc. Natl Acad. Sci. U S A 99:6163-6168, 2002.
150. You, X., A. W. Nguyen, A. Jabaiah, M. A. Sheff, K. S. Thorn, et al. Intracellular protein interaction mapping with FRET hybrids. Proc. Natl Acad. Sci. USA 103:18458-18463, 2006.
151. Zhang, L., C. A. Athale, and T. S. Deisboeck. Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J. Theor. Biol. 244:96-107, 2007.
152. Zhang, L., C. G. Strouthos, Z. Wang, and T. S. Deisboeck. Simulating brain tumor heterogeneity with a multiscale agent-based model: Linking molecular signatures, phenotypes and expansion rate. Math. Comput. Model. 49:307-319, 2009.
153. Zheng, Y., J. Chen, M. Craven, N. W. Choi, S. Totorica, et al. In vitro microvessels for the study of angiogenesis and thrombosis. Proc. Natl Acad. Sci. U S A 109:9342-9347, 2012.